MillennialEYE named Kathryn M. Hatch, MD, an “Outstanding female leader in ophthalmology” in their January/February 2017, and published a profile about her career and work. MillennialEYE is an all-digital publication and online community for the future leaders in ophthalmology....
Mass. Eye and Earwas included in Boston Magazine's "Boston Hospitals with Niche Specialties," as the only hospital with a 24/7 eye emergency room in New England. See the full article in Boston Magazine.
ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, is one of five of the world’s premier retinal disease thought leaders who will serve on its newly formed scientific advisory board (SAB). The goal of...
David Sullivan and his family were featured in a Review of Optometry editorial for their "vision and dedication in unravelling the mysteries of dry eye disease."
Mass. Eye and Ear's Boston KPro was credited as the most widely used artificial cornea in an article from Ophthalmology Times on the use of bioengineered corneas.
Endre A. Balazs, a pioneer in viscoelastic therapeutics and a leader in hyaluronan and vitreous research, passed away on August 29th at the age of 95. Dr. Balazs had a central role in establishingwhat is now Schepens Eye Research Institute, and was awarded the Institute's...
Boston, MA Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently...
Jonathan Talamo, MD, from Mass. Eye and Ear’s Waltham location,was quoted in an article about advances in laser technology and physicians' attitudes toward this dramatic evolution. While some doctors are skeptical of new technology, Dr. Talamo believes laser cataract surgery can create safer and more predictable procedures, and will continue to gain popularity.
Kathryn M. Hatch, MD was quoted in an article in Ocular Surgery News. She was corresponding author on a study that found the use of intraocular aberrometry during cataract surgery with TORIC intraocular lens (IOL) implantation reduced postoperative residual refractive astigmatism compared to eyes undergoing surgery without aberrometry.
Scott Greenstein, MDwas quoted in an article for theHuffington Postabout ways that certain ocular problems can be signs of underlying issues. For example, if the eyelids are unable to close, this may be a symptom of facial nerve paralysis, which can be a feature of Lyme Disease. Additionally, extreme dryness could be a sign of an autoimmune disease.
Louis Pasquale, MDof Mass. Eye and Ear's Glaucoma Service and Thomas Merrill, OD, optician and manager of Mass. Eye and Ear Optical Services, were quoted in an article on protecting eyes from sun damage. Dr. Pasquale stressed the danger of reflective surfaces, such as water or snow, to eyes, and Thomas added that quality sunglasses will provide the best protection.
The remarkable story of Charles L. Schepens, MD, is featured in the June 2015 issue of EyeWorld: The Newsmagazine of the American Society of Cataract & Refractive Surgery. Dr. Schepens is widely known as the Father of Modern Retinal Surgery and the founder of what is now the Schepens Eye Research Institute. However, his lesser-known role as...